SRD5A2 rs121434250: Understanding 5-Alpha-Reductase 2 Deficiency
The rs121434250 variant is a specific genetic change located within the SRD5A2 gene. It is associated with 5-alpha-reductase 2 deficiency, a condition that can affect sexual development by altering how the body processes certain hormones.
What each genotype means
Typical enzyme function
This is the common, wild-type genotype for the SRD5A2 gene. Individuals with this genotype are not expected to have the specific pathogenic variant associated with 5-alpha-reductase 2 deficiency.
This is the most common genotype found in the general population.
Carrier status
This genotype indicates you carry one copy of the pathogenic variant associated with 5-alpha-reductase 2 deficiency. Because this condition is inherited in an autosomal recessive manner, carriers typically do not exhibit symptoms, but you should discuss the implications of this carrier status with a genetic counselor or clinician.
This specific variant is rare in the general population.
Potential enzyme deficiency
This genotype indicates you carry two copies of the pathogenic variant associated with 5-alpha-reductase 2 deficiency. This condition is linked to atypical sexual development in males, and you should consult with a medical professional or specialist to discuss what this means for your health.
This genotype is extremely rare in the general population.
What is the rs121434250 Variant?
The rs121434250 variant is a single nucleotide polymorphism (SNP) located on chromosome 2 within the SRD5A2 gene. In genetic databases, this variant is often studied for its potential to disrupt the normal function of the gene. Genetic variants are essentially variations in the DNA sequence that can occur naturally across the human population. While many variants have no observable effect on health, some are classified as pathogenic if they significantly alter the function of a protein. The rs121434250 variant is specifically noted in clinical databases for its association with 5-alpha-reductase 2 deficiency. Understanding this variant requires looking at its position within the gene and how that specific location influences the production of the steroid 5-alpha-reductase 2 enzyme. Because this is a rare variant, it is not commonly found in the general population, and its presence is typically investigated in the context of specific clinical presentations related to sexual development.
The Role of the SRD5A2 Gene
The SRD5A2 gene provides the essential instructions for the body to create an enzyme known as steroid 5-alpha-reductase 2. This enzyme plays a critical role in the endocrine system, specifically in the metabolism of androgens. Its primary function is to convert testosterone into dihydrotestosterone (DHT). DHT is a much more potent androgen than testosterone and is vital for the normal development of male sex characteristics, particularly during the prenatal period when external genitalia are formed. When the SRD5A2 gene contains a variant that impairs the function of this enzyme, the conversion of testosterone to DHT is reduced. This hormonal imbalance can lead to atypical sexual development, as the body lacks the necessary levels of DHT to complete the standard masculinization process. The severity of the impact on development often depends on the extent to which the enzyme's activity is reduced by the specific genetic variant present.
Research and Clinical Significance
Research into the SRD5A2 gene has established a clear link between certain variants and 5-alpha-reductase 2 deficiency, an autosomal recessive disorder. This means that for an individual to be affected by the condition, they typically need to inherit two copies of a pathogenic variant—one from each parent. Clinical evidence, including data found in resources like ClinVar, classifies specific variants in this gene as pathogenic due to their role in disrupting hormone conversion. Studies have documented that individuals with this deficiency may present with a range of genital appearances at birth, sometimes appearing female or having ambiguous genitalia, despite having male gonads. During puberty, some individuals may experience further virilization due to the surge in testosterone, which can partially compensate for the lack of DHT. It is important to note that while the association between SRD5A2 variants and this condition is well-documented, the clinical expression can vary significantly between individuals.
Population Frequency and Interpretation
The rs121434250 variant is considered rare in the general population. Because it is a rare variant, it is not typically screened for in standard, broad-spectrum genetic testing panels unless there is a specific clinical indication. In population genetics, rare variants are often found at very low frequencies across different ancestral groups. If you have received information about this variant, it is essential to understand that genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or a medical geneticist. They can provide context based on your personal and family medical history. This information is for educational purposes and should not be used to diagnose any condition. If you have concerns about your health or the results of a genetic test, please consult with your clinician to discuss the findings and any potential implications for your health or family planning.
How common is this variant?
The rs121434250 variant is rare in the general population, with its specific frequency varying by ancestry and typically appearing at very low levels in global databases.
Frequently asked questions
What is 5-alpha-reductase 2 deficiency?
It is a rare genetic condition that affects male sexual development. It occurs when the body cannot effectively convert testosterone into dihydrotestosterone (DHT), which is necessary for the development of male external genitalia.
Is rs121434250 a common genetic variant?
No, rs121434250 is considered a rare variant. It is not commonly found in the general population.
What should I do if I have this variant?
If you have concerns about a genetic test result, you should discuss it with a healthcare provider or a genetic counselor. They can help you understand what the result means in the context of your personal health and family history.
Can this variant be treated?
Management of 5-alpha-reductase 2 deficiency is handled by medical specialists, such as endocrinologists. Treatment options depend on the individual's specific clinical presentation and should be discussed with a qualified medical professional.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121434250?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29